Search results
Dow Jones Inches Up As Nvidia Rallies On These Calls; Retailer On 64% Run Clears New Entry
Investor's Business Daily· 13 hours agoThe Dow Jones was up on the stock market today. AI leader Nvidia got some price target hikes. Li...
8. ElevateBio
CNBC· 7 days agoIn a banner 2023, life sciences company ElevateBio struck new biotech R&D collaborations with a former No. 1 Disruptor, Moderna, and high-flying drug...
Arbutus urged to halt share issuances amid patent disputes By Investing.com
Investing.com· 3 days ago(NASDAQ: NASDAQ:ABUS), has publicly urged the biopharmaceutical company to stop issuing shares to...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 6 days agoIn 2020, the industry was thrust into the pandemic limelight as Pfizer and its partner BioNTech,...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 7 days agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
S&P 500 Gains and Losses Today: Norwegian Cruise Soars on Guidance, Strategy Update
Investopedia· 22 hours agoIn the days ahead, quarterly results from semiconductor giant Nvidia (NVDA) could provide a gauge of...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 2 days agoNovavax is pursuing full approval for Nuvaxovid in the U.S. It will likely earn the nod, but how...
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 5 days agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...
Lonza stock holds Buy rating with higher target By Investing.com
Investing.com· 7 days agoThe year 2024 is anticipated to be a period of transition for Lonza, with projected lower earnings...
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Zacks via Yahoo Finance· 5 days agoFulcrum and Sanofi will equally share future global development costs. FULC retains full...